The most frequent p53 missense mutations in cancer are found within the DNA-binding domain (DBD; Supplementary Fig. S1A and S1B), where all mutations result in lower target gene expression through the loss of DNA-binding affinity (6). This evidence concerns the gene TP53 and cancer.